Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018

Summary

The trial is an interventional, cluster-randomized trial to assess the impact of oral ciprofloxacin for household and community contacts of meningitis cases on the incidence of meningitis during an epidemic. The trial contains a nested sub-study ("resistance study") to assess the effect of a single dose of ciprofloxacin on the prevalence of fluoroquinolone-resistant enterobacteriaceae in the study area.

Timeline

Start

2019-03-01

Primary completion

2019-06-30

Completion

2019-12-31

Drugs

Indications